Probiotics in Wellbeing
PROBIOTICS IN WELLBEING (PiW) STUDY
A randomised controlled trial investigating the probiotic-mediated suppression of inflammatory cytokines as a mechanism for improving wellbeing.
Ìý
Purpose of the study
The purpose of this project is to find out whether taking a daily probiotic supplement can shift immune activity and, in turn, improve wellbeing.
The study will look at whether the probiotic can reduce low levels of inflammation detected in the blood and if this is linked with changes in mood and wellbeing in healthy adults. The probiotic used is
a commercially available food supplement that has been used safely in previous studies.
Ìý
Who can take part in this study?
• Adults aged from 18 to 60 years in general good health and no gut-related conditions, Ìýsuch as IBS, IBD, coeliac disease.
• BMI between 18.5 and 30 kg/m2.
• Able to communicate in English.
Ìý
Exclusion criteria
You areÌýnotÌýeligible to take part in the study if any of the following applies to you:
• Have taken an experimental drug within four weeks prior to the start of the study.
• Previously participated in prebiotic, probiotic or laxative trials within the previous four weeks.
• Previously participated in a dietary intervention within the previous four weeks.
• Used antibiotics within the previous four weeks.
• Have taken other specific prebiotics (such as oligosaccharides e.g. inulin), or probiotics (e.g. live yoghurts, other fermented products, like kefir or kombucha), for four weeks prior to study.
Have taken drugs that act on gastrointestinal motility, or a laxative of any class, for four weeks prior to study.
• Use anti-inflammatory drugs, weight-loss medications, psychotropics or drugs which suppress the immune system.
• Are lactating, pregnant or planning pregnancy during the study period.
• Have been diagnosed with mild cognitive impairment or dementia.
Ìý
What will taking part in the study involve?
This study will compare a probiotic supplement with a placebo (a “dummy� supplement that looks and tastes the same) to see whether it may affect wellbeing. It will also examine changes in
metabolism and the gut microbiome (the community of bacteria living in the gut).
The study will last for 12 weeks.
Ìý
Screening visit
Completing an online medical and lifestyle questionnaire to assess eligibility.
Preparation for study visits
Completing online questionnaires about wellbeing and memory, urine and stool sample collection, and completing a 24-hour food diary online via Intake24 software.
Ìý
Main study visits
Baseline study visit - (Week 0)
Taking the supplement - (Weeks 0–12)
End-of-study visit - (Week 12)
Ìý
Study contact
Please contact probioticsinwellbeing@reading.ac.uk Ìýfor more information about this study.